Antipyretic effect of ketoprofen

S Celebi1, M Hacimustafaoglu, D Aygun

  • 1Uludag University Faculty of Medicine Department of Pediatrics, Bursa, Turkey. solmaz@uludag.edu.tr

Insights

Ketoprofen, acetaminophen, and ibuprofen showed similar efficacy and safety for fever reduction in children. Patient compliance regarding taste was also comparable across the three antipyretic drugs.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Clinical Medicine

Background:

  • Fever is a common symptom in children requiring effective and safe antipyretic treatment.
  • Acetaminophen and ibuprofen are widely used antipyretics, but ketoprofen's role is less established.
  • Evaluating ketoprofen's efficacy, side effects, and patient compliance is crucial for expanding treatment options.

Purpose of the Study:

  • To compare the efficacy and side effect profile of ketoprofen with acetaminophen and ibuprofen in pediatric patients.
  • To assess patient compliance, specifically regarding drug taste, for ketoprofen versus acetaminophen and ibuprofen.
  • To determine if ketoprofen can serve as a viable alternative antipyretic agent.

Main Methods:

  • A randomized study involving 301 pediatric patients (1-14 years) with fever requiring antipyretic therapy.
  • Patients received acetaminophen (15 mg/kg/dose), ketoprofen (0.5 mg/kg/dose), or ibuprofen (10 mg/kg/dose).
  • Fever reduction was monitored for 4-6 hours, with assessments at 30, 60, 120 minutes, and 4-6 hours post-administration. Side effects and taste compliance were also recorded.

Main Results:

  • No significant differences in fever reduction were observed among the three drug groups at any time point (30, 60, 120 minutes, 4-6 hours).
  • Incidence of vomiting and reported bad taste did not significantly differ between ketoprofen, acetaminophen, and ibuprofen groups.
  • No significant differences were found in antipyretic effect, taste, or adverse effects across different age groups.

Conclusions:

  • Ketoprofen, acetaminophen, and ibuprofen demonstrate comparable efficacy in reducing fever in pediatric patients.
  • The side effect profiles and patient compliance related to taste are similar for all three studied antipyretics.
  • Ketoprofen is a suitable alternative to acetaminophen and ibuprofen for pediatric fever management.
Abstract

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...